Adam Rosenberg

Chief Executive Officer at Aliada Therapeutics, Inc.

Health Technology

Profile

Adam Rosenberg is currently the Chief Executive Officer and Director at Aliada Therapeutics, Inc. He previously worked as a Director at Ambagon Therapeutics, Inc.

Adam Rosenberg active positions

Companies	Position	Start
Aliada Therapeutics, Inc. Aliada Therapeutics, Inc. BiotechnologyHealth Technology Aliada Therapeutics, Inc. is a neuroscience-focused company that aims to overcome the delivery hurdle in large molecule drug development. The company is based in Boston, MA. The company is advancing a generation of CNS therapeutics using its novel BBB crossing platform technology, which can efficiently transport a diverse array of therapeutic cargoes into the brain, resulting in enhanced downstream effectiveness. Aliada Therapeutics was founded by Sanjaya Singh, and the CEO is Adam Rosenberg.	Chief Executive Officer	-

All active positions of Adam Rosenberg

Former positions of Adam Rosenberg

Companies	Position	End
Ambagon Therapeutics, Inc. Ambagon Therapeutics, Inc. BiotechnologyHealth Technology Ambagon Therapeutics, Inc. provides healthcare services. It specializes in biotechnology. The company is headquartered in San Francisco, CA.	Director/Board Member	-

See the detail of Adam Rosenberg's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Adam Rosenberg's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Ambagon Therapeutics, Inc. Ambagon Therapeutics, Inc. BiotechnologyHealth Technology Ambagon Therapeutics, Inc. provides healthcare services. It specializes in biotechnology. The company is headquartered in San Francisco, CA.	Health Technology
Aliada Therapeutics, Inc. Aliada Therapeutics, Inc. BiotechnologyHealth Technology Aliada Therapeutics, Inc. is a neuroscience-focused company that aims to overcome the delivery hurdle in large molecule drug development. The company is based in Boston, MA. The company is advancing a generation of CNS therapeutics using its novel BBB crossing platform technology, which can efficiently transport a diverse array of therapeutic cargoes into the brain, resulting in enhanced downstream effectiveness. Aliada Therapeutics was founded by Sanjaya Singh, and the CEO is Adam Rosenberg.	Health Technology